NCT00003428View on ClinicalTrials.gov

Hormone Therapy in Treating Women With Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

May 31, 1998

Primary Completion Date

June 30, 2001

Study Completion Date

June 30, 2001

Conditions
Breast Cancer
Interventions
DRUG

arzoxifene hydrochloride

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00003428 - Hormone Therapy in Treating Women With Breast Cancer | Biotech Hunter | Biotech Hunter